Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Psychophysiology. 2019 Apr 10;56(8):e13377. doi: 10.1111/psyp.13377

Table 3.

Covariate Analysis

PTSD Symptoms: CAPS-5 Scores
B SE B β p
Model 1
 Intercept 28.01 2.90 <0.001
 Age −0.25 0.30 −0.16 0.413
 Sex 2.74 2.74 0.18 0.325
 Race −2.39 3.06 −0.14 0.440
Model 2
 Intercept 23.84 2.02 <0.001
 Age −0.33 0.23 −0.21 0.162
 Sex 0.07 1.78 0.01 0.967
 Race −0.37 1.92 −0.02 0.847
 HRV1 −2.88 0.94 −0.41 0.005
 Condition2 −4.01 1.80 −0.26 0.034
 Interaction3 −1.58 0.83 −0.21 0.069
 Baseline CAPS-54 0.88 0.13 0.71 <0.001
Substance Use: TLFB Scores
B SE B β p

Model 1

 Intercept 33.64 8.24 <0.001
 Age −0.74 0.87 −0.16 0.400
 Sex 5.84 7.80 0.14 0.460
 Race 3.91 8.71 0.08 0.657
Model 2
 Intercept 34.45 9.18 <0.001
 Age 0.16 1.07 0.04 0.882
 Sex 5.56 8.37 0.13 0.512
 Race 2.34 8.83 0.49 0.793
 HRV1 6.97 4.39 0.35 0.124
 Condition2 6.81 8.13 0.15 0.409
 Interaction3 −1.62 3.87 −0.80 0.678
 Baseline TLFB5 0.22 0.21 0.20 0.288

Note.

1

Baseline resting heart rate variability.

2

Treatment condition.

3

Heart rate variability multiplied by treatment condition.

4

Clinician Administered PTSD Scale.

5

Timeline Follow Back.